Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Use this ATNM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ATNM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ATNM SEC filings page. Lician reads the product cache first so this HTML stays unique to Actinium Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ATNM income, balance, and cash tables.